Cite Filings / DNTH / 0000902664-25-004074

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Dianthus Therapeutics, Inc. /DE/ Filed 2025-09-12 Acc 0000902664-25-004074

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-12 SCHEDULE 13G Statement of Beneficial Ownership
2025-09-12 SCHEDULE 13G Statement of Beneficial Ownership
2025-09-11 8-K Material agreement
2025-09-11 424B5 Prospectus
2025-09-11 4 CFO & CBO sold 20,000 shares at $35.00 ($700,000)
2025-09-09 144 Sale of Securities
2025-05-15 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…